Paper7604013
Characterization of the VHL tumor suppressor gene product: localization, complex formation, and the effect of natural inactivating mutations.
Duan DR and 8 others. Proc Natl Acad Sci U S A, 1995. Cited by 128 papers, by iCite.
Cite this record
ConductScience Library. Characterization of the VHL tumor suppressor gene product: localization, complex formation, and the effect of natural inactivating mutations. Papers, record 7604013. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/7604013
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics23
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Genes, Tumor Suppressor | Major topic |
| Ligases | Major topic |
| Nuclear Proteins | Major topic |
| Tumor Suppressor Proteins | Major topic |
| Ubiquitin-Protein Ligases | Major topic |
| von Hippel-Lindau Disease | Major topic |
| Amino Acid Sequence | |
| Animals | |
| Base Sequence | |
| Cell Line | |
| Chlorocebus aethiops | |
| DNA, Complementary | |
| HeLa Cells | |
| Humans | |
| Kidney | |
| Molecular Sequence Data | |
| Rats | |
| Recombinant Proteins | |
| Sequence Homology, Amino Acid | |
| Sequence Homology, Nucleic Acid | |
| Subcellular Fractions | |
| Transfection | |
| Von Hippel-Lindau Tumor Suppressor Protein |
Source PubMed
References14
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 7728151 | Germline mutations in the von Hippel-Lindau disease tumor suppressor gene: correlations with phenotype. | Hum Mutat | 1995 | https://conductscience.org/library/papers/7728151 | PubMed |
| 2 | 2827008 | SR alpha promoter: an efficient and versatile mammalian cDNA expression system composed of the simian virus 40 early promoter and the R-U5 segment of human T-cell leukemia virus type 1 long terminal repeat. | Mol Cell Biol | 1988 | https://conductscience.org/library/papers/2827008 | PubMed |
| 3 | 1717476 | Human cyclins A and B1 are differentially located in the cell and undergo cell cycle-dependent nuclear transport. | J Cell Biol | 1991 | https://conductscience.org/library/papers/1717476 | PubMed |
| 4 | 8422679 | A nuclear pore complex protein that contains zinc finger motifs, binds DNA, and faces the nucleoplasm. | Cell | 1993 | https://conductscience.org/library/papers/8422679 | PubMed |
| 5 | 8436587 | Localization of TGN38 to the trans-Golgi network: involvement of a cytoplasmic tyrosine-containing sequence. | J Cell Biol | 1993 | https://conductscience.org/library/papers/8436587 | PubMed |
| 6 | 8493574 | Identification of the von Hippel-Lindau disease tumor suppressor gene. | Science | 1993 | https://conductscience.org/library/papers/8493574 | PubMed |
| 7 | 7850784 | Cloning and characterization of a mouse gene with homology to the human von Hippel-Lindau disease tumor suppressor gene: implications for the potential organization of the human von Hippel-Lindau disease gene. | Cancer Res | 1995 | https://conductscience.org/library/papers/7850784 | PubMed |
| 8 | 8187067 | Frequent somatic mutations and loss of heterozygosity of the von Hippel-Lindau tumor suppressor gene in primary human renal cell carcinomas. | Cancer Res | 1994 | https://conductscience.org/library/papers/8187067 | PubMed |
| 9 | 8193533 | Tumor suppressor genes. | Curr Opin Genet Dev | 1994 | https://conductscience.org/library/papers/8193533 | PubMed |
| 10 | 7915601 | Mutations of the VHL tumour suppressor gene in renal carcinoma. | Nat Genet | 1994 | https://conductscience.org/library/papers/7915601 | PubMed |
| 11 | 7937876 | Silencing of the VHL tumor-suppressor gene by DNA methylation in renal carcinoma. | Proc Natl Acad Sci U S A | 1994 | https://conductscience.org/library/papers/7937876 | PubMed |
| 12 | 7987306 | Identification of intragenic mutations in the von Hippel-Lindau disease tumour suppressor gene and correlation with disease phenotype. | Hum Mol Genet | 1994 | https://conductscience.org/library/papers/7987306 | PubMed |
| 13 | 7837390 | Identification of the von Hippel-Lindau (VHL) gene. Its role in renal cancer. | JAMA | 1995 | https://conductscience.org/library/papers/7837390 | PubMed |
| 14 | 7902574 | Antioncogenes and human cancer. | Proc Natl Acad Sci U S A | 1993 | https://conductscience.org/library/papers/7902574 | PubMed |
Cited by41
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 128 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 41526504 | Targeting and dissociating HIF2α from the molecular chaperone Hsp70 triggers apoptosis in kidney cancer. | Commun Med (Lond) | 2026 | https://conductscience.org/library/papers/41526504 | PubMed |
| 37477829 | Genome editing and cancer therapy: handling the hypoxia-responsive pathway as a promising strategy. | Cell Mol Life Sci | 2023 | https://conductscience.org/library/papers/37477829 | PubMed |
| 36835292 | Role of SOCS and VHL Proteins in Neuronal Differentiation and Development. | Int J Mol Sci | 2023 | https://conductscience.org/library/papers/36835292 | PubMed |
| 35110537 | Deubiquitylase OTUD6B stabilizes the mutated pVHL and suppresses cell migration in clear cell renal cell carcinoma. | Cell Death Dis | 2022 | https://conductscience.org/library/papers/35110537 | PubMed |
| 29662541 | Cabozantinib in the treatment of advanced renal cell carcinoma in adults following prior vascular endothelial growth factor targeted therapy: clinical trial evidence and experience. | Ther Adv Urol | 2018 | https://conductscience.org/library/papers/29662541 | PubMed |
| 27620538 | William Kaelin, Peter Ratcliffe, and Gregg Semenza receive the 2016 Albert Lasker Basic Medical Research Award. | J Clin Invest | 2016 | https://conductscience.org/library/papers/27620538 | PubMed |
| 27155521 | Structure, function and regulation of jade family PHD finger 1 (JADE1). | Gene | 2016 | https://conductscience.org/library/papers/27155521 | PubMed |
| 26973240 | Phosphorylation-dependent cleavage regulates von Hippel Lindau proteostasis and function. | Oncogene | 2016 | https://conductscience.org/library/papers/26973240 | PubMed |
| 26323595 | A Novel von Hippel Lindau Gene Intronic Variant and Its Reclassification from VUS to Pathogenic: the Impact on a Large Family. | J Genet Couns | 2015 | https://conductscience.org/library/papers/26323595 | PubMed |
| 25310726 | Computational and experimental characterization of dVHL establish a Drosophila model of VHL syndrome. | PLoS One | 2014 | https://conductscience.org/library/papers/25310726 | PubMed |
| 24969085 | An integrated computational approach can classify VHL missense mutations according to risk of clear cell renal carcinoma. | Hum Mol Genet | 2014 | https://conductscience.org/library/papers/24969085 | PubMed |
| 23840444 | Structural insights into the folding defects of oncogenic pVHL lead to correction of its function in vitro. | PLoS One | 2013 | https://conductscience.org/library/papers/23840444 | PubMed |
| 22370733 | Pancreatic lesions in von Hippel-Lindau disease? A systematic review and meta-synthesis of the literature. | J Gastrointest Surg | 2012 | https://conductscience.org/library/papers/22370733 | PubMed |
| 20638985 | Characterization of the expression, localization, and secretion of PANDER in alpha-cells. | Mol Cell Endocrinol | 2010 | https://conductscience.org/library/papers/20638985 | PubMed |
| 18836774 | Computational detection of deleterious SNPs and their effect on sequence and structural level of the VHL gene. | Mamm Genome | 2008 | https://conductscience.org/library/papers/18836774 | PubMed |
| 18799446 | Neurologic manifestations of von Hippel-Lindau disease. | JAMA | 2008 | https://conductscience.org/library/papers/18799446 | PubMed |
| 18542780 | Current understanding of the molecular mechanisms of kidney cancer: a primer for urologists. | Can Urol Assoc J | 2007 | https://conductscience.org/library/papers/18542780 | PubMed |
| 18195360 | Allosteric effects in the marginally stable von Hippel-Lindau tumor suppressor protein and allostery-based rescue mutant design. | Proc Natl Acad Sci U S A | 2008 | https://conductscience.org/library/papers/18195360 | PubMed |
| 17526729 | Hypoxia-inducible factor linked to differential kidney cancer risk seen with type 2A and type 2B VHL mutations. | Mol Cell Biol | 2007 | https://conductscience.org/library/papers/17526729 | PubMed |
| 15904470 | A tumor-specific gene therapy strategy targeting dysregulation of the VHL/HIF pathway in renal cell carcinomas. | Cancer Sci | 2005 | https://conductscience.org/library/papers/15904470 | PubMed |
Genes3
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| CDKN2A | 1029 | PubTator's text mining | https://conductscience.org/library/genes/1029 | NCBI Gene |
| EXOSC8 | 11340 | PubTator's text mining | https://conductscience.org/library/genes/11340 | NCBI Gene |
| VHL | 7428 | PubTator's text mining | https://conductscience.org/library/genes/7428 | NCBI Gene |
Data1
The data bank entries PubMed's record names. Trial numbers are under Trials.
| Data bank | Accession |
|---|---|
| GENBANK | U14746 |
Source GENBANK
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/7604013
GET https://conductscience.org/api/papers/v1/7604013/cited_by?page=2